Physician profile

George Sokos

Advanced Heart Failure and Transplant Cardiology · Morgantown, WV

NPI 1922277235

$13,744.95

in general payments reported to CMS, 2019-2025

32 companies · $633 in 2025

The $633 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).

See the full distribution for Advanced Heart Failure and Transplant Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,234.50
Travel and Lodging$748.64
Education$344.96

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Actelion Pharmaceuticals US, INC. $5,198.11 2019-2025 Uptravi, Opsumit
Medtronic Vascular, INC. $1,647.66 2019
Abbott Laboratories $1,353.14 2019-2025 Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems
Heartflow, INC. $1,194.94 2022-2025 Ffrct
Endotronix, INC. $817.93 2022-2024 Cordella Pulomonary Artery Pressure Sensor
Abiomed $739.14 2021-2024 Impella
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $705.32 2019-2025 Lifevest
Cvrx, INC. $629.41 2021-2025 Barostim Neo System
E.R. Squibb & Sons, L.L.C. $356.17 2022-2023 Camzyos
Impulse Dynamics (USA) INC. $172.24 2022-2023 Optimizer
Merck Sharp & Dohme LLC $147.77 2024
Novartis Pharmaceuticals Corporation $93.64 2019
Medtronic, INC. $81.47 2021-2025 Corevalve Evolut R
Pfizer INC. $77.32 2019-2020
Boston Scientific Corporation $74.73 2019-2022
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $73.11 2022-2024 Brilinta, Wainua
Novo Nordisk INC $65.91 2021-2022
Takeda Pharmaceuticals U.S.A., INC. $53.95 2025 Livtencity
Cleerly, INC. $37.82 2023 Cleerly Labs
Lantheus Medical Imaging, INC. $36.55 2023 Definity
Sandoz INC. $36.06 2023 Treprostinil
Emd Serono, INC. $28.75 2024
Livanova USA, INC. $27.32 2019
Amgen INC. $23.90 2019
Vifor Pharma, INC. $20.89 2020
W. L. Gore & Associates, INC. $18.68 2024 Gore Cardioform Septal Occluder
Boehringer Ingelheim Pharmaceuticals, INC. $18.10 2022
Ethicon US, LLC $14.92 2024 Vistaseal, Evarrest, Surgicel Nu-Knit

4 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

George Sokos

$13,744.95

in general payments reported 2019-2025

Years
2019-2025
Top company
Actelion Pharmaceuticals US, INC.
Context
The $633 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).

https://glasscript.com/doctor/132497/george-sokos

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.